tradingkey.logo
tradingkey.logo
Search

Embecta Corp

EMBC
Add to Watchlist
3.350USD
-0.010-0.30%
Close 07/02, 13:00ETQuotes delayed by 15 min
198.75MMarket Cap
1.75P/E TTM

TradingKey Stock Score of Embecta Corp

Currency: USD Updated: 2026-07-02

Key Insights

Embecta Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 87 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 10.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Embecta Corp's Score

Industry at a Glance

Industry Ranking
87 / 204
Overall Ranking
200 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Embecta Corp Highlights

StrengthsRisks
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.08B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 38.36%.
Undervalued
The company’s latest PE is 1.75, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 59.40M shares, decreasing 7.24% quarter-over-quarter.
Held by Donald Yacktman
Star Investor Donald Yacktman holds 9.87M shares of this stock.

Analyst Rating

Based on 4 analysts
Hold
Current Rating
10.000
Target Price
+197.62%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Embecta Corp?

The TradingKey Stock Score provides a comprehensive assessment of Embecta Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Embecta Corp’s performance and outlook.

How do we generate the financial health score of Embecta Corp?

To generate the financial health score of Embecta Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Embecta Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Embecta Corp.

How do we generate the company valuation score of Embecta Corp?

To generate the company valuation score of Embecta Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Embecta Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Embecta Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Embecta Corp.

How do we generate the earnings forecast score of Embecta Corp?

To calculate the earnings forecast score of Embecta Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Embecta Corp’s future.

How do we generate the price momentum score of Embecta Corp?

When generating the price momentum score for Embecta Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Embecta Corp’s prices. A higher score indicates a more stable short-term price trend for Embecta Corp.

How do we generate the institutional confidence score of Embecta Corp?

To generate the institutional confidence score of Embecta Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Embecta Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Embecta Corp.

How do we generate the risk management score of Embecta Corp?

To assess the risk management score of Embecta Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Embecta Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Embecta Corp.